LLY

1,064.6

+0.54%↑

JNJ

204.44

+0.26%↑

ABBV

230.76

-2.29%↓

UNH

318.93

-0.13%↓

AZN

91.79

+0.86%↑

LLY

1,064.6

+0.54%↑

JNJ

204.44

+0.26%↑

ABBV

230.76

-2.29%↓

UNH

318.93

-0.13%↓

AZN

91.79

+0.86%↑

LLY

1,064.6

+0.54%↑

JNJ

204.44

+0.26%↑

ABBV

230.76

-2.29%↓

UNH

318.93

-0.13%↓

AZN

91.79

+0.86%↑

LLY

1,064.6

+0.54%↑

JNJ

204.44

+0.26%↑

ABBV

230.76

-2.29%↓

UNH

318.93

-0.13%↓

AZN

91.79

+0.86%↑

LLY

1,064.6

+0.54%↑

JNJ

204.44

+0.26%↑

ABBV

230.76

-2.29%↓

UNH

318.93

-0.13%↓

AZN

91.79

+0.86%↑

Inicio・Lista de Acciones・Avita Therapeutics Inc

Avita Therapeutics Inc

Abierto

3.73 -1.32

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.6

Máximo

3.7800000000000002

Métricas clave
By Trading Economics
Ingresos	-3.3M -13M
Ventas	-1.4M 17M
BPA	-0.712
Margen de beneficios	-77.289
Empleados	260
EBITDA	4M -8.1M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+121.11% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-3.4M 118M
Apertura anterior	5.05
Cierre anterior	3.73

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

8.83 / 9.77 Soporte y Resistencia

Avita Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 nov 2025, 22:23 UTC

Adquisiciones, fusiones, absorciones

BHP Abandons Bid for Anglo American Following New Talks

23 nov 2025, 22:16 UTC

Adquisiciones, fusiones, absorciones

Macquarie Proposes $7.5 Billion Takeover of Logistics Operator Qube

23 nov 2025, 22:01 UTC

Adquisiciones, fusiones, absorciones

Macquarie Proposes $7.5B Takeover of Logistics Operator Qube

23 nov 2025, 19:00 UTC

Ganancias

Dell, HP Inc., Alibaba, Zoom, Deere, and More Stocks to Watch This Week -- Barrons.com

23 nov 2025, 00:50 UTC

Ganancias

Wall Street Goes on a Wild Ride: 'No One Was Expecting This' -- WSJ

22 nov 2025, 10:30 UTC

Ganancias

How Google Finally Leapfrogged Rivals With New Gemini Rollout -- WSJ

22 nov 2025, 10:30 UTC

Adquisiciones, fusiones, absorciones

Investors Clamor for a Peek Behind the Private Markets Curtain -- WSJ

22 nov 2025, 09:20 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

21 nov 2025, 22:42 UTC

Charlas de Mercado

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21 nov 2025, 21:50 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

21 nov 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

21 nov 2025, 21:47 UTC

Charlas de Mercado

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21 nov 2025, 21:43 UTC

Charlas de Mercado

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21 nov 2025, 20:18 UTC

Charlas de Mercado

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21 nov 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21 nov 2025, 19:48 UTC

Charlas de Mercado

Precious Metals Fall for the Week -- Market Talk

21 nov 2025, 19:44 UTC

Ganancias

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21 nov 2025, 19:37 UTC

Charlas de Mercado

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21 nov 2025, 19:27 UTC

Charlas de Mercado

Ganancias

Global Equities Roundup: Market Talk

21 nov 2025, 19:27 UTC

Charlas de Mercado

Ganancias

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21 nov 2025, 19:20 UTC

Charlas de Mercado

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21 nov 2025, 18:44 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21 nov 2025, 18:37 UTC

Charlas de Mercado

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21 nov 2025, 18:34 UTC

Charlas de Mercado

Ganancias

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21 nov 2025, 18:28 UTC

Ganancias

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21 nov 2025, 18:03 UTC

Charlas de Mercado

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21 nov 2025, 17:24 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

21 nov 2025, 17:24 UTC

Charlas de Mercado

Intuit Seen on Path to Increase Growth -- Market Talk

21 nov 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

21 nov 2025, 17:05 UTC

Charlas de Mercado

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc previsión

Precio Objetivo

By TipRanks

121.11% repunte

Estimación a 12 Meses

Media 8.38 USD 121.11%

Máximo 14 USD

Mínimo 3 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Avita Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.83 / 9.77Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.